These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

177 related items for PubMed ID: 7850208

  • 1. Molecular mechanisms of drug resistance in fungi.
    Vanden Bossche H, Marichal P, Odds FC.
    Trends Microbiol; 1994 Oct; 2(10):393-400. PubMed ID: 7850208
    [Abstract] [Full Text] [Related]

  • 2. Species and susceptibility distribution of 1062 clinical yeast isolates to azoles, echinocandins, flucytosine and amphotericin B from a multi-centre study.
    Schmalreck AF, Willinger B, Haase G, Blum G, Lass-Flörl C, Fegeler W, Becker K, Antifungal Susceptibility Testing-AFST Study Group.
    Mycoses; 2012 May; 55(3):e124-37. PubMed ID: 22233267
    [Abstract] [Full Text] [Related]

  • 3. [Molecular and biochemical mechanisms of drug resistance in fungi].
    Yamaguchi H.
    Nihon Ishinkin Gakkai Zasshi; 1999 May; 40(4):199-208. PubMed ID: 10536306
    [Abstract] [Full Text] [Related]

  • 4. In vitro antifungal susceptibilities of isolates of Candida spp. and Aspergillus spp. from China to nine systemically active antifungal agents: data from the SENTRY antifungal surveillance program, 2010 through 2012.
    Pfaller MA, Castanheira M, Messer SA, Jones RN.
    Mycoses; 2015 Apr; 58(4):209-14. PubMed ID: 25727853
    [Abstract] [Full Text] [Related]

  • 5. Efficacy of amphotericin B and flucytosine against fluconazole-resistant Candida inconspicua clinical isolates.
    Majoros L, Kardos G, Feiszt P, Szabó B.
    J Antimicrob Chemother; 2005 Jul; 56(1):253-4. PubMed ID: 15911550
    [No Abstract] [Full Text] [Related]

  • 6. Antifungal drug resistance in pathogenic fungi.
    Vanden Bossche H, Dromer F, Improvisi I, Lozano-Chiu M, Rex JH, Sanglard D.
    Med Mycol; 1998 Jul; 36 Suppl 1():119-28. PubMed ID: 9988500
    [Abstract] [Full Text] [Related]

  • 7. Drug resistance in Candida albicans and Candida glabrata.
    Kerridge D, Fasoli M, Wayman FJ.
    Ann N Y Acad Sci; 1988 Jul; 544():245-59. PubMed ID: 3063171
    [No Abstract] [Full Text] [Related]

  • 8. Resistance of yeasts to azole-derivative antifungals.
    Odds FC.
    J Antimicrob Chemother; 1993 Apr; 31(4):463-71. PubMed ID: 8514644
    [Abstract] [Full Text] [Related]

  • 9. [INVESTIGATION ON ANTIFUNGAL SUSCEPTIBILITY OF CANDIDA YEASTS IN PREGNANT PATIENTS WITH CONFIRMED VULVOVAGINAL CANDIDIASIS AND THEIR NEWBORNS.].
    Chokoeva A, Kouzmanov A, Ivanova Z, Zisova L, Amalie G, Petleshkova P, Miteva-Katrandzhieva T, Krasteva M, Uchikova E.
    Akush Ginekol (Sofiia); 2016 Apr; 55(4):20-29. PubMed ID: 29370489
    [Abstract] [Full Text] [Related]

  • 10. Resistance of Candida species to antifungal agents: molecular mechanisms and clinical consequences.
    Sanglard D, Odds FC.
    Lancet Infect Dis; 2002 Feb; 2(2):73-85. PubMed ID: 11901654
    [Abstract] [Full Text] [Related]

  • 11. A multicentre study of antifungal susceptibility patterns among 350 Candida auris isolates (2009-17) in India: role of the ERG11 and FKS1 genes in azole and echinocandin resistance.
    Chowdhary A, Prakash A, Sharma C, Kordalewska M, Kumar A, Sarma S, Tarai B, Singh A, Upadhyaya G, Upadhyay S, Yadav P, Singh PK, Khillan V, Sachdeva N, Perlin DS, Meis JF.
    J Antimicrob Chemother; 2018 Apr 01; 73(4):891-899. PubMed ID: 29325167
    [Abstract] [Full Text] [Related]

  • 12. Mechanisms and clinical impact of antifungal drug resistance.
    Vanden Bossche H, Warnock DW, Dupont B, Kerridge D, Sen Gupta S, Improvisi L, Marichal P, Odds FC, Provost F, Ronin O.
    J Med Vet Mycol; 1994 Apr 01; 32 Suppl 1():189-202. PubMed ID: 7722785
    [No Abstract] [Full Text] [Related]

  • 13. Multi-centre evaluation of the Etest method for antifungal drug susceptibility testing of Candida spp. and Cryptococcus neoformans. BSAC Working Party on Antifungal Chemotherapy.
    Warnock DW, Johnson EM, Rogers TR.
    J Antimicrob Chemother; 1998 Sep 01; 42(3):321-31. PubMed ID: 9786472
    [Abstract] [Full Text] [Related]

  • 14. High prevalence of antifungal resistance in Candida spp. from patients with AIDS.
    Law D, Moore CB, Wardle HM, Ganguli LA, Keaney MG, Denning DW.
    J Antimicrob Chemother; 1994 Nov 01; 34(5):659-68. PubMed ID: 7706161
    [Abstract] [Full Text] [Related]

  • 15. [Mechanisms of resistance to antifungal agents].
    Makimura K.
    Nihon Rinsho; 2007 Feb 28; 65 Suppl 2 Pt. 1():466-70. PubMed ID: 17455664
    [No Abstract] [Full Text] [Related]

  • 16. Clinical applicability of antifungal susceptibility testing on non-Candida albicans species in hospitalized patients.
    Wong-Beringera A, Hindler J, Brankovic L, Muehlbauer L, Steele-Moore L.
    Diagn Microbiol Infect Dis; 2001 Jan 28; 39(1):25-31. PubMed ID: 11173188
    [Abstract] [Full Text] [Related]

  • 17. Monitoring Antifungal Resistance in a Global Collection of Invasive Yeasts and Molds: Application of CLSI Epidemiological Cutoff Values and Whole-Genome Sequencing Analysis for Detection of Azole Resistance in Candida albicans.
    Castanheira M, Deshpande LM, Davis AP, Rhomberg PR, Pfaller MA.
    Antimicrob Agents Chemother; 2017 Oct 28; 61(10):. PubMed ID: 28784671
    [Abstract] [Full Text] [Related]

  • 18. Resistance in human pathogenic yeasts and filamentous fungi: prevalence, underlying molecular mechanisms and link to the use of antifungals in humans and the environment.
    Jensen RH.
    Dan Med J; 2016 Oct 28; 63(10):. PubMed ID: 27697142
    [Abstract] [Full Text] [Related]

  • 19. Has antifungal susceptibility testing come of age?
    Rex JH, Pfaller MA.
    Clin Infect Dis; 2002 Oct 15; 35(8):982-9. PubMed ID: 12355386
    [Abstract] [Full Text] [Related]

  • 20. [Antifungals cellular targets and mechanisms of resistance].
    Accoceberry I, Noël T.
    Therapie; 2006 Oct 15; 61(3):195-9. PubMed ID: 16989119
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.